IL6 and plasma cell myeloma: As an assessment of infection status at the time of surgery was made, CRP rather appears to act as a surrogate marker for IL-6 activity and proliferative status of bone marrow plasma cells and has been regarded as a powerful prognostic marker in patients with multiple myeloma, than a sign for preoperative infectious states.